CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 87 filers reported holding CARDIFF ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,795 | -5.4% | 16,399 | 0.0% | 0.00% | – |
| Q2 2023 | $24,107 | -10.9% | 16,399 | 0.0% | 0.00% | – |
| Q1 2023 | $27,058 | +17.9% | 16,399 | 0.0% | 0.00% | – |
| Q4 2022 | $22,959 | -11.7% | 16,399 | 0.0% | 0.00% | – |
| Q3 2022 | $26,000 | -29.7% | 16,399 | 0.0% | 0.00% | – |
| Q2 2022 | $37,000 | -85.5% | 16,399 | -84.1% | 0.00% | – |
| Q1 2022 | $256,000 | -56.5% | 103,143 | +5.5% | 0.00% | – |
| Q4 2021 | $588,000 | -9.8% | 97,763 | 0.0% | 0.00% | – |
| Q3 2021 | $652,000 | +14.4% | 97,763 | +14.2% | 0.00% | – |
| Q2 2021 | $570,000 | +243.4% | 85,617 | +635.8% | 0.00% | – |
| Q3 2020 | $166,000 | – | 11,636 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $16,797,000 | 13.61% |
| Octagon Capital Advisors LP | 982,753 | $6,545,000 | 1.61% |
| Altium Capital Management LP | 348,888 | $2,324,000 | 0.61% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $683,000 | 0.35% |
| Eventide Asset Management | 1,670,399 | $11,125,000 | 0.15% |
| Artal Group S.A. | 750,000 | $4,995,000 | 0.11% |
| Virtus ETF Advisers LLC | 25,770 | $172,000 | 0.08% |
| HighVista Strategies LLC | 15,501 | $103,000 | 0.07% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 13,500 | $90,000 | 0.05% |
| SCHOLTZ & COMPANY, LLC | 16,625 | $111,000 | 0.04% |